This month of May is ALS Awareness Month, and marks an opportune time to spotlight the disease and the importance of ...

As we move deeper into may, the East Texas harvest season will begin to show, whether its a bumper crop or a ‘break even’ season.

Clene (NASDAQ: CLNN) announced first quarter 2025 financial results and progress on its CNM-Au8 program for ALS and MS. The company is preparing for ...

According to Fire Marshal Kevin May, the fire at the house in the 300 block of Marion Street started around 8:30 a.m.

STATEN ISLAND, N.Y. — Robert Moffit, a lifelong Staten Island resident who became an advocate for New York’s Medical Aid in ...

Late last year, the therapy developers dosed their first patient following positive preclinical data demonstrating safety and ...

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that preclinical research exploring key mechanisms underlying amyotrophic lateral sclerosis (ALS) pathology will be presented at the 2025 ...

Company Logo Dr. Gomez brings extensive neuroscience and orphan disease development experience to Raya as it plans multiple clinical trials ...

Spinogenix has received clearance from the U.S. Food and Drug Administration (FDA) to launch an expanded access program (EAP) ...

Brooke Eby was just 33 when she was diagnosed in 2022 with amyotrophic lateral sclerosis—ALS, otherwise known as Lou Gehrig's ...

Pivotal Phase 3 LUCIDITY trial of avexitide, a potential first-in-class GLP-1 receptor antagonist with FDA breakthrough therapy designation, underway in post-bariatric hypoglycemia (PBH); completion ...

Smith's synthetic voice was created by analyzing old recordings made before his illness, allowing him to regain a voice for his thoughts and communicate in a voice similar to his own.